Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) shares rose 4.2% during trading on Monday. The stock traded as high as $26.82 and last traded at $26.75. 12,886 shares were traded during mid-day trading, a decline of 98% from the average session volume of 795,882 shares. The stock had previously closed at $25.66.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on MD shares. Weiss Ratings raised Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, September 9th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $25.00 price objective on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. UBS Group upped their target price on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Finally, Jefferies Financial Group downgraded shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and increased their price target for the stock from $27.00 to $28.00 in a research report on Wednesday, August 19th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $26.60.
Check Out Our Latest Stock Report on Pediatrix Medical Group
Pediatrix Medical Group Stock Down 1.6%
Pediatrix Medical Group (NYSE:MD – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The business had revenue of $487.78 million for the quarter, compared to analysts’ expectations of $478.49 million. During the same quarter in the previous year, the company earned $0.53 EPS. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current year.
Hedge Funds Weigh In On Pediatrix Medical Group
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Tidal Investments LLC grew its holdings in shares of Pediatrix Medical Group by 253.9% in the second quarter. Tidal Investments LLC now owns 616,048 shares of the company’s stock valued at $15,604,000 after purchasing an additional 441,959 shares in the last quarter. WINTON GROUP Ltd raised its stake in Pediatrix Medical Group by 8.9% during the second quarter. WINTON GROUP Ltd now owns 57,413 shares of the company’s stock valued at $1,454,000 after purchasing an additional 4,710 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in Pediatrix Medical Group during the second quarter valued at $53,000. Nykredit A S purchased a new position in shares of Pediatrix Medical Group in the 2nd quarter worth $35,000. Finally, Corient Private Wealth LP purchased a new position in shares of Pediatrix Medical Group in the 2nd quarter worth $832,000. 97.71% of the stock is owned by institutional investors.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc is a physician-led healthcare services company that provides specialized medical care for women, infants and children. The company partners with hospitals and health systems to deliver care through physician practices, neonatal intensive care units and other hospital-based programs.
Its services include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric hospital medicine and other pediatric subspecialties. Pediatrix physicians care for patients before, during and after childbirth, as well as children requiring specialized or critical care.
Read More
- Five stocks we like better than Pediatrix Medical Group
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
- 2 China-Focused ETFs For After the Trump-Xi Summit
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
